Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
We summarize typical holdings and how index funds achieve broad market exposure with a defined set of constituents.
15,010 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Mara Holdings and Riot Platforms fell Friday as higher energy costs collide with investors' questions about AI-driven...
When a top executive unloads stock, it signals more than a simple liquidity move. This article breaks down Privia Hea...
When a company director sells a large block of stock, it can raise questions. This guide explains what signals to wat...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
Could a single Vanguard ETF outpace the S&P 500 in 2026? This article breaks down why broad market exposure, discipli...
This year could bring a bigger tax refund than you expect. Learn how to allocate it wisely with a simple plan that bo...
A fresh ETF blends SCHD with an options overlay to target about twice the underlying yield. The approach promises hig...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
cdl’s $2.29 annual dividend remains resilient as Treasuries climb, offering a steady monthly cash flow through a uniq...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
A new stake in VOYA Financial by Gator Capital Management is turning heads among investors. This article breaks down ...